Streetbeat News

Revenues

KW

Kennedy Wilson's real estate debt investment platform has grown significantly, reaching $7B in originations. This growth was propelled by the acquisition of a $4.1 billion loan portfolio from a regional bank and the integration of its lending team. The company has since closed $500 million of new loans and expects to close an additional $1.3 billion by Q2 2024, focusing on multifamily and student housing construction lending.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:22 am

ELV

Elevance Health's four Medicare Advantage contracts will receive higher 2024 Star Ratings, positively impacting its 2025 revenue by an estimated $190M. This adjustment follows a reconsideration of the initial ratings announced in October 2023.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 11:18 am

M

Macy's Inc (NYSE:M) stock is surging due to a revised takeover bid of $24.00 per share in cash from Arkhouse Management Co. LP and Brigade Capital Management, LP, representing a 33.3% premium over its March 1, 2024, closing price. This follows Macy's rejection of an initial offer and comes amid a board challenge from Arkhouse. Macy's Q4 revenue declined 1.4% YOY, and the company plans to close 150 locations by 2026.

Portfolio Pulse from Shivani Kumaresan

March 04, 2024 | 11:02 am

HTOO

Fusion Fuel (HTOO) has been awarded a €1.015 million grant from the European Innovation Fund's Horizon Europe Programme as part of the H2tALENT consortium. This consortium, which includes 29 partners from six European countries and is sponsored by the Universidade de Évora, aims to develop small-scale hydrogen valleys to showcase hydrogen's decarbonization potential across the entire value chain.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 9:22 am

BAYRY

BBIO

BridgeBio Pharma and Bayer have entered into a licensing agreement for acoramidis in Europe, targeting ATTR-CM. BridgeBio will receive up to $310 million in payments plus royalties. Their New Drug Application for acoramidis has been accepted by the FDA, with a PDUFA date set for November 29, 2024, and the EMA has accepted the Marketing Authorization Application, expecting approval in 2025.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 7:34 am

LIFW

LifeWallet has reached a comprehensive settlement with 28 insurers, significantly benefiting its Medicare client services across the United States. This settlement is expected to enhance the company's service offerings and potentially improve its financial stability by securing more predictable revenue streams from these insurers.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 6:20 am

EWA

Australia's company gross operating profits for Q4 showed a significant increase of 7.4%, surpassing the estimated 1.1%. This is a notable improvement from the -1.6% (revised) reported in the previous quarter.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 5:31 am

EWA

Australia's Building Approvals for January showed a decrease of 1.0% month-over-month, contrasting with the estimated 3.8% increase and a significant revision from the prior -10.1%.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 5:30 am

BBJP

DXJ

EWJ

Japan's capital spending for Q4 surged to 16.4%, significantly exceeding the estimated 2.9% and the prior 3.4%, indicating a robust investment environment in Japan.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 5:29 am

IGT

IPG

RELY

ZBH

Barron's cover story highlights the best luxury second home resort markets in the US, with Austin, Texas, Lake Geneva, Wisconsin, and Park City, Utah topping the list. Luxury second home prices rose 11% in 2015. The article also discusses investment opportunities in hedge funds through closed-end funds run by Bill Ackman and Dan Loeb, and mentions stocks like Interpublic Group (IPG), Zimmer Biomet Holdings (ZBH), Real Industry (RELY), and International Game Technology (IGT) for their potential.

Portfolio Pulse from Nelson Hem

March 03, 2024 | 9:37 pm